Notably, alterations in gut microbiota composition observed in obesity may influence innate immune signaling by increasing the systemic availability of microbial‐derived ligands, such as peptidoglycan fragments, which can engage receptors like NOD1 (Cuevas‐Sierra et al., 2019). The gene discussed is NOD1; the disease is obesity due to melanocortin 4 receptor deficiency.